BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28539121)

  • 21. Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing.
    Zhao K; So HC
    Methods Mol Biol; 2019; 1903():219-237. PubMed ID: 30547445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review of network-based approaches to drug repositioning.
    Lotfi Shahreza M; Ghadiri N; Mousavi SR; Varshosaz J; Green JR
    Brief Bioinform; 2018 Sep; 19(5):878-892. PubMed ID: 28334136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Network mirroring for drug repositioning.
    Park S; Lee DG; Shin H
    BMC Med Inform Decis Mak; 2017 May; 17(Suppl 1):55. PubMed ID: 28539121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DrugNet: network-based drug-disease prioritization by integrating heterogeneous data.
    Martínez V; Navarro C; Cano C; Fajardo W; Blanco A
    Artif Intell Med; 2015 Jan; 63(1):41-9. PubMed ID: 25704113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug Repositioning to Accelerate Drug Development Using Social Media Data: Computational Study on Parkinson Disease.
    Zhao M; Yang CC
    J Med Internet Res; 2018 Oct; 20(10):e271. PubMed ID: 30309833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug Repositioning by Integrating Known Disease-Gene and Drug-Target Associations in a Semi-supervised Learning Model.
    Le DH; Nguyen-Ngoc D
    Acta Biotheor; 2018 Dec; 66(4):315-331. PubMed ID: 29700660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting associations among drugs, targets and diseases by tensor decomposition for drug repositioning.
    Wang R; Li S; Cheng L; Wong MH; Leung KS
    BMC Bioinformatics; 2019 Dec; 20(Suppl 26):628. PubMed ID: 31839008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug Repositioning for Schizophrenia and Depression/Anxiety Disorders: A Machine Learning Approach Leveraging Expression Data.
    Zhao K; So HC
    IEEE J Biomed Health Inform; 2019 May; 23(3):1304-1315. PubMed ID: 30010603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CLASH: Complementary Linkage with Anchoring and Scoring for Heterogeneous biomolecular and clinical data.
    Nam Y; Kim M; Lee K; Shin H
    BMC Med Inform Decis Mak; 2016 Jul; 16 Suppl 3(Suppl 3):72. PubMed ID: 27454118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DCDB 2.0: a major update of the drug combination database.
    Liu Y; Wei Q; Yu G; Gai W; Li Y; Chen X
    Database (Oxford); 2014; 2014():bau124. PubMed ID: 25539768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tolfenamic acid reduces tau and CDK5 levels: implications for dementia and tauopathies.
    Adwan L; Subaiea GM; Basha R; Zawia NH
    J Neurochem; 2015 Apr; 133(2):266-72. PubMed ID: 25279694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PubChem BioAssay: 2014 update.
    Wang Y; Suzek T; Zhang J; Wang J; He S; Cheng T; Shoemaker BA; Gindulyte A; Bryant SH
    Nucleic Acids Res; 2014 Jan; 42(Database issue):D1075-82. PubMed ID: 24198245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer survivability prediction using labeled, unlabeled, and pseudo-labeled patient data.
    Kim J; Shin H
    J Am Med Inform Assoc; 2013; 20(4):613-8. PubMed ID: 23467471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computational drug repositioning: from data to therapeutics.
    Hurle MR; Yang L; Xie Q; Rajpal DK; Sanseau P; Agarwal P
    Clin Pharmacol Ther; 2013 Apr; 93(4):335-41. PubMed ID: 23443757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The global prevalence of dementia: a systematic review and metaanalysis.
    Prince M; Bryce R; Albanese E; Wimo A; Ribeiro W; Ferri CP
    Alzheimers Dement; 2013 Jan; 9(1):63-75.e2. PubMed ID: 23305823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Comparative Toxicogenomics Database: update 2013.
    Davis AP; Murphy CG; Johnson R; Lay JM; Lennon-Hopkins K; Saraceni-Richards C; Sciaky D; King BL; Rosenstein MC; Wiegers TC; Mattingly CJ
    Nucleic Acids Res; 2013 Jan; 41(Database issue):D1104-14. PubMed ID: 23093600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacogenomics knowledge for personalized medicine.
    Whirl-Carrillo M; McDonagh EM; Hebert JM; Gong L; Sangkuhl K; Thorn CF; Altman RB; Klein TE
    Clin Pharmacol Ther; 2012 Oct; 92(4):414-7. PubMed ID: 22992668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In silico drug repositioning: what we need to know.
    Liu Z; Fang H; Reagan K; Xu X; Mendrick DL; Slikker W; Tong W
    Drug Discov Today; 2013 Feb; 18(3-4):110-5. PubMed ID: 22935104
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.